PURE Bioscience Inc (OTCPK:PURE)
$ 0.0869 -0.01165 (-11.82%) Market Cap: 9.72 Mil Enterprise Value: 12.32 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2019 PURE Biosciences Inc Earnings Call Transcript

Mar 06, 2019 / 09:30PM GMT
Release Date Price: $0.47 (+4.44%)
Operator

Thank you for standing by. This is the conference operator. Welcome to the PURE Bioscience Fiscal Q2 2019 Results Conference Call. (Operator Instructions)

I would now like to turn the conference over to Terri MacInnis, Vice President of Investor Relations at Bibicoff + MacInnis, Inc. Please go ahead.

Terri MacInnis
Bibicoff & Macinnis, Inc. - VP of IR

Thank you, Shenae, and good afternoon, everyone. It's my pleasure to welcome you to the company's conference call to discuss fiscal 2019 Q2 and 6-month financial and operating results and an update on PURE's food safety business strategy. On our call today is Hank Lambert, Chief Executive Officer; and Mark Elliott, VP, Finance.

This afternoon, PURE issued a financial results news release and filed its fiscal Q2 report on Form 10-Q, copies of which are available on the SEC's website and the Investor Relations page of PURE's website, purebio.com. This call is being webcast live and recorded. A replay of the event will be posted later today on the company's website and will remain available

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot